COMMENTARY: Persistent right ventricular dysfunction increased risk for recurrent venous thromboembolism after acute pulmonary embolism

Douketis, James; Kaatz, Scott
March 2007
ACP Journal Club;Mar/Apr2007, Vol. 146 Issue 2, p46
Academic Journal
The article presents the authors' views about a study which states that persistent right ventricular dysfunction (RVD) increased risk for recurrent venous thromboembolism (VTE) after acute pulmonary embolism (PE). Although the findings of the study has been associated with increased short-term mortality, the use of more aggressive thrombolytic therapy does not reduce mortality or recurrent VTE more than does conventional anticoagulation.


Related Articles

  • Acute Massive Pulmonary Embolism with Cardiopulmonary Resuscitation. Konstantinov, Igor E.; Saxena, Pankaj; Koniuszko, Miriam D.; Alvarez, John; Newman, Mark A. J. // Texas Heart Institute Journal;2007, Vol. 34 Issue 1, p41 

    Patients who experience hemodynamic collapse after acute massive pulmonary embolism have a poor prognosis. Herein, we report our results with 8 patients and discuss a surgical strategy that can improve perioperative survival. From August 1994 through May 2005, 8 consecutive patients (6 women, 2...

  • Morphologic characteristics of central pulmonary thromboemboli predict haemodynamic response in massive pulmonary embolism. Podbregar, Matej; Voga, Gorazd; Krivec, Bojan // Intensive Care Medicine;Aug2004, Vol. 30 Issue 8, p1552 

    Objective: On hospital admission, the morphology of the central pulmonary artery thromboemboli is an independent predictor of 30-day mortality in patients with massive pulmonary embolism (MPE). This may be due to the differential susceptibility of thromboemboli to thrombolysis. The...

  • THROMBOLYSIS AS AN ALTERNATIVE TO PULMONARY EMBOLECTOMY. Porter, John M. // Vascular Surgery;Nov/Dec1977, Vol. 11 Issue 6, p373 

    Discusses the potential application of thrombolysis as an alternative to pulmonary embolectomy. Incidence and acute survival statistics of pulmonary embolism; Role of heparin in the treatment of pulmonary embolism; Evaluation of streptokinase and urokinase as thrombolytic agents.

  • Is Thrombolytic Therapy Effective for Pulmonary Embolism? Almoosa, Khalid // American Family Physician;3/15/2002, Vol. 65 Issue 6, p1097 

    Pulmonary embolism is a disorder that is associated with significant morbidity and mortality. Right-sided heart failure and recurrent pulmonary embolism are the main causes of death associated with pulmonary embolism in the first two weeks after the embolic event. Thrombolysis is a potentially...

  • Thrombolysis Not Helpful for Unselected Patients with PE. Ebell, Mark // American Family Physician;1/15/2005, Vol. 71 Issue 2, p352 

    Discusses research being done on the use of thrombolytic therapy for patients with pulmonary embolism (PE). Reference to a study by S. Wan et al published in the August 10, 2004 issue of "Circulation"; Reduction in the likelihood of PE or death in patients with major hemodynamically unstable...

  • A Case of a Serpentine-like Right Atrial Thrombus Causing Pulmonary Embolism. Aksakal, Enbiya; Emet, Mücahit; Değirmenci, Hüsnü; Uzkeser, Mustafa // Journal of Academic Emergency Medicine Case Reports / Akademik A;2012, Vol. 3 Issue 4, p134 

    Right atrial thrombi are rare but cause mortality in approximately 30-40% of cases. Echocardiography is important for determining the causes of the cardiac origin of pulmonary embolism, and, simultaneously, mobile thrombi can be rarely visualized in the right atrium and pulmonary artery....

  • Salvage intraosseous thrombolysis and extracorporeal membrane oxygenation for massive pulmonary embolism. Northey, Luke Cameron; Shiraev, Timothy; Omari, Abdullah // Journal of Emergencies, Trauma & Shock;Jan-Mar2015, Vol. 8 Issue 1, p55 

    Intraosseous access is an alternative route of pharmacotherapy during cardiopulmonary resuscitation. Extracorporeal membrane oxygenation (ECMO) provides cardiac and respiratory support when conventional therapies fail. This case reports the use of intraosseous thrombolysis and ECMO in a patient...

  • Thrombolytic Therapy: Agents, Indication, Clinical Performance, and Side Effects. Tilsner, V.; Greul, W. // Vascular Surgery;Mar/Apr1979, Vol. 13 Issue 2, p79 

    Thrombolytic therapy is successful in 70% of fresh occlusions and in over 40% of chronic occlusions. Vascular surgery is often superior to thrombolytic therapy on the arterial side, but inferior on the venous side. Streptokinase acts faster and is considerably cheaper than urokinase, but it...

  • Endovascular management of acute limb ischemia. Sedghi, Yabiz; Collins, Tyrone J; White, Christopher J // Vascular Medicine;Oct2013, Vol. 18 Issue 5, p307 

    Acute limb ischemia (ALI) is defined as a sudden decrease (<14 days) in limb perfusion causing a potential threat to limb viability. Endovascular treatment of ALI is an effective and appropriate primary treatment strategy in patients with a viable acutely ischemic limb due to a recent arterial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics